Archive for the 'Respiratory & Asthma' Category


Common Food Additive Found To Increase Risk And Speed Spread Of Lung Cancer

New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease. The study also suggests that dietary regulation of inorganic phosphates may play an important role in lung cancer treatment.
(more...)


Family Members Of Critically Ill Patients Want To Discuss Loved Ones’ Uncertain Prognoses

Critically ill patients frequently have uncertain prognoses, but their families overwhelmingly wish that physicians would address prognostic uncertainty candidly, according to a new study out of the University of San Francisco Medical Center. "Our interviews revealed that caregivers appear to believe that some uncertainty is unavoidable, and just the nature of life," said lead author Douglas White, M.D., M.A.S.
(more...)


Anti-Fungal Drug Offers Great Benefits To Some With Severe Asthma

Some patients with severe asthma who also have allergic sensitivity to certain fungi enjoy great improvements in their quality of life and on other measures after taking an antifungal drug, according to new research from The University of Manchester in England. The findings were reported in the first issue for January of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
(more...)


Study Of New Drug To Stimulate Immune System Of Cancer Victims: TGen, Scottsdale Healthcare, Mayo Clinic

The Translational Genomics Research Institute (TGen), Scottsdale Healthcare and Mayo Clinic are testing a new drug that could help cancer patients by stimulating the immune system. Clinical trials of the drug VTX-2337 are being conducted at TGen Clinical Research Services at Scottsdale Healthcare, a partnership of Phoenix-based TGen and Scottsdale-based Scottsdale Healthcare Corp., and at Mayo Clinic in Arizona. Dr.
(more...)


First Lung Lesion And First Lymph Node Metastasis Treated With AngioDynamics’ IRE Technology At Australia’s The Alfred Hospital

AngioDynamics, Inc. (NASDAQ:ANGO) announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case, at The Alfred in Melbourne, Australia. Using the NanoKnifeā„¢ system, Dr. Ken Thomson, Professor and Director of the Department of Radiology at The Alfred, Monash University, performed the procedures, which were judged by The Alfred to be successful from a safety perspective.
(more...)


Nrf2 Could Be Novel Target For COPD Prevention Therapies

Using a molecule similar to one found in an experimental cancer drug, researchers at the Johns Hopkins Bloomberg School of Public Health demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice. The researchers believe that activation of Nrf2 could be a novel target for therapies to prevent chronic obstructive pulmonary disease (COPD), which comprises emphysema and chronic bronchitis.
(more...)


King Of Pop’s Reported Diagnosis Sheds Light On Relatively Unknown Disease

In light of reports that Michael Jackson is suffering from a rare respiratory condition caused by Alpha 1-Antitrypsin Deficiency, Jeffrey Teckman, M.D., associate professor of pediatrics, biochemistry and molecular biology at Saint Louis University School of Medicine, is available to talk about the diagnosis, causes and treatment of the disease.
(more...)


NicOx Announces Results For TPI 1020 In COPD

NicOx S.A. (NYSE Euronext Paris: COX) announced the results of a phase 2a study for TPI 1020, conducted in 62 patients with Chronic Obstructive Pulmonary Disease (COPD) by its partner Topigen Pharmaceuticals Inc. TPI 1020 showed good overall safety and tolerability, although its activity profile was not significantly different from budesonide, a conventional corticosteroid commonly used in respiratory disorders.
(more...)


Undetected Tuberculosis Is A Threat Cheap Reliable Diagnosis Needed

The EAGLES International Symposium report on Tuberculosis Research, Shenzhen, China, 5-7 November 2008 is now available. It concludes that TB is the most important infectious disease in China. Millions of people from Asia, South America and Africa are carriers of latent TB infections. The threat of TB outbreaks even in Europe and America costs countries 100s of millions of Euros to control every year.
(more...)


Breathing Life Into Injured Lungs: World-First Technique Expands Donor Pool

For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient. The use of this technique could significantly expand the lung donor organ pool and improve outcomes after transplantation. In their ground-breaking research, a team of lung transplant surgeons led by Dr.
(more...)